Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 15 of 15

List	Outcome	Time frame	Description
Primary	Target MAP (Mean Arterial Pressure) >65 mm Hg at 6 hrs	6 hours
Secondary	Maintenance of target MAP (Mean Arterial Pressure)	2 days	MAP is Mean Arterial pressure SVR is Sustained Virologic Response
Secondary	Survival	28 days
Secondary	Survival	48 hours
Secondary	Microcirculation (lactate level, Lactate clearance, SCVO2, ABG-VBG Pco2 difference),	2 years
Secondary	Tissue perfusion (lactate level, Lactate clearance, SCVO2, ABG-VBG Pco2 difference),	2 years
Secondary	Effect on - AKI (Acute kidney Injury),	2 years
Secondary	Effect on variceal bleed	2 years
Secondary	Effect on rebound hypotension	2 years
Secondary	Effect on organ failure	2 years
Secondary	Length of ICU	2 years
Secondary	Length of hospital stay.	2 years
Secondary	Incidence of adverse events.	2 years
Secondary	Predictors of adverse events.	2 years
Secondary	SVR (Sustained Virologic Response) ≥600 at 48 hrs	2 days

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02468063/registered